- In forming the special committee, the Board of Directors of Genentech resolved that the Board would not recommend to stockholders or otherwise approve a merger or other business combination transaction with Roche without the prior favorable recommendation of the special committee.
- The special committee has retained Goldman, Sachs & Co. to act as its financial advisor, and Latham & Watkins LLP as its legal counsel.

Other headlines for [DNA]

• BCE 11/26/2008 07:30am
  BCE Inc. (USA) Statement regarding privatization transaction, feels may not meet schedule of privatization- Received a preliminary view from KPMG that, based on current market conditions, its analysis to date and more...
  
• DNA 11/25/2008 07:43am
  Genentech Inc Enters new collaboration with Dako on a companion diagnostic for a targeted cancer therapy- The collaboration involves the use of Dako's extensive experience in developing cancer diagnostic tests to more...
  
• DNA 11/25/2008 04:54am
  Genentech Inc Roche remains committed to Genentech deal- Aims to reach an agreed settlement in near future - Note: On 11/09, Roche's CEO said "We are sticking with our plan to buy the remaining 44% of Genentech."
  
• DNA 11/24/2008 07:05pm
  Genentech Inc A major study found that AVASTIN delayed progression of breast cancer when combined with commonly used chemotherapies - WSJ- The 1,237 patient study showed that AVASTIN plus several different more...
  
• DNA 11/18/2008 04:00pm
  Genentech Inc Study confirms increased risk of blood clots in veins with AVASTIN - Journal of American Medical Association- Genentech says that the risk is already reflected in prescribing information. - more...
  

Healthcare sector headlines

• NCST Today 09:48am
  Nucryst Pharmaceuticals Corp Majority holder calls for special meeting of shareholders to consider a return of capital of $0.80/shr
  
• GNBT Today 09:30am
  Generex Biotechnology Announces Positive Results of Metformin Chewing Gum Trial- Results of this fully compliant ICH-GCP conducted study indicate that the MetControl Metformin chewing gum and traditional Metformin tablets more...
  
• Today 09:30am
  Fed sets overnight reverse repos, accepts $25B
  
• 4568.JP Today 09:28am
  Daiichi Sankyo Co Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology- Results from three studies of its investigational molecule, DU-176b, will more...
  
• GENZ Today 09:22am
  Genzyme Corp European Patent on cross-linked Gel Slurries has been revoked by EPO board of appeal- Announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation has been more...